UB Paderborn / Katalog / Suche / in CDI

HLA genotype and cortical lesions: Response to the letter from Spencer et al

Multiple sclerosis, 2018-05, Vol.24 (6), p.819-820

2018

Link zum Volltext

Verfügbarkeit prüfen

Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination

Journal of neuroinflammation, 2021-06, Vol.18 (1), p.126-126, Article 126

2021

Link zum Volltext

Verfügbarkeit prüfen

HLA-DRB104:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis

Multiple sclerosis, 2018-05, Vol.24 (6), p.710-720

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are associated with a better outcome

Journal of neuroinflammation, 2019-09, Vol.16 (1), p.179-179, Article 179

2019

Link zum Volltext

Verfügbarkeit prüfen

Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis

Scientific reports, 2020-03, Vol.10 (1), p.5228-5228, Article 5228

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age

EBioMedicine, 2022-08, Vol.82, p.104179-104179, Article 104179

2022

Link zum Volltext

Verfügbarkeit prüfen

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

Journal of neuroinflammation, 2018-09, Vol.15 (1), p.255-255, Article 255

2018

Link zum Volltext

Verfügbarkeit prüfen

A case of overlapping adult‐onset linear scleroderma and Parry‐Romberg syndrome presenting with widespread ipsilateral neurogenic involvement

Neuropathology, 2020-02, Vol.40 (1), p.109-115

2020

Link zum Volltext

Verfügbarkeit prüfen

Environmental risk factors for multiple sclerosis in Japanese people

Multiple sclerosis and related disorders, 2020-02, Vol.38, p.101872, Article 101872

2020

Link zum Volltext

Verfügbarkeit prüfen

Association of Decreased Percentage of Vδ2 + Vγ9 + γδ T Cells With Disease Severity in Multiple Sclerosis

Frontiers in immunology, 2018-04, Vol.9, p.748-748

2018

Link zum Volltext

Verfügbarkeit prüfen

CD30 ligand is a new therapeutic target for central nervous system autoimmunity

Journal of autoimmunity, 2015-02, Vol.57, p.14-23

2015

Link zum Volltext

Verfügbarkeit prüfen

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Clinical & experimental neuroimmunology, 2015-05, Vol.6 (2), p.111-112

2015

Link zum Volltext

Verfügbarkeit prüfen

Creutzfeldt–Jakob disease‐like diffusion‐weighted imaging hyperintensity paralleled with neuropsychiatric symptoms in a patient with limbic encephalitis associated with anti‐voltage‐gated potassium channel complex antibodies

Clinical & experimental neuroimmunology, 2019-08, Vol.10 (3), p.204-206

2019

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood T cell subset characteristics of multiple sclerosis in remission phase correlate with annualized relapse rates

Clinical & experimental neuroimmunology, 2016-11, Vol.7 (4), p.346-352

2016

Link zum Volltext

Verfügbarkeit prüfen

The 32nd European Committee for Treatment and Research in Multiple Sclerosis

Clinical & experimental neuroimmunology, 2017-02, Vol.8 (1), p.82-85

2017

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (3), p.e2207291120-e2207291120

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Application of a New Compact Computed Tomography System for Evaluating the Outcome of Regenerative Therapy: A Case Report

Journal of periodontology (1970), 2001-05, Vol.72 (5), p.696-702

2001

Link zum Volltext

Verfügbarkeit prüfen

CD 30 ligand could be a new therapeutic target for central nervous system autoimmunity

Clinical & experimental neuroimmunology, 2015-05, Vol.6 (2), p.111-112

2015

Link zum Volltext

Verfügbarkeit prüfen

Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis

Journal of the neurological sciences, 2020-02, Vol.409, p.116619-116619, Article 116619

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis

Journal of the neurological sciences, 2020-06, Vol.413, p.116768-116768, Article 116768

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-term use of interferon-[beta] in multiple sclerosis increases V[delta]1-V[delta]2-V[gamma]9- [gamma][delta] T cells that are associated with a better outcome

Journal of neuroinflammation, 2019-09, Vol.16 (1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis

Journal of neuroimmunology, 2016-02, Vol.291, p.39-45

2016

Link zum Volltext

Verfügbarkeit prüfen

Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study

Neurology : neuroimmunology & neuroinflammation, 2022-03, Vol.9 (2)

2022

Link zum Volltext

Verfügbarkeit prüfen

Re-emergence of a tumefactive demyelinating lesion after initiation of fingolimod therapy

Journal of the neurological sciences, 2017-08, Vol.379, p.167-168

2017

Link zum Volltext

Verfügbarkeit prüfen

A novel mutation in FGD4 causes Charcot–Marie–Tooth disease type 4H with cranial nerve involvement

Neuromuscular disorders : NMD, 2017-10, Vol.27 (10), p.959-961

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

HLA genotype and cortical lesions: Response to the letter from Spencer et al

Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination

HLA-DRB104:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis

Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are associated with a better outcome

Contribution of cortical lesions to cognitive impairment in Japanese patients with multiple sclerosis

Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression

A case of overlapping adult‐onset linear scleroderma and Parry‐Romberg syndrome presenting with widespread ipsilateral neurogenic involvement

Environmental risk factors for multiple sclerosis in Japanese people

Association of Decreased Percentage of Vδ2 + Vγ9 + γδ T Cells With Disease Severity in Multiple Sclerosis

CD30 ligand is a new therapeutic target for central nervous system autoimmunity

CD30 ligand could be a new therapeutic target for central nervous system autoimmunity

Creutzfeldt–Jakob disease‐like diffusion‐weighted imaging hyperintensity paralleled with neuropsychiatric symptoms in a patient with limbic encephalitis associated with anti‐voltage‐gated potassium channel complex antibodies

Peripheral blood T cell subset characteristics of multiple sclerosis in remission phase correlate with annualized relapse rates

The 32nd European Committee for Treatment and Research in Multiple Sclerosis

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Clinical Application of a New Compact Computed Tomography System for Evaluating the Outcome of Regenerative Therapy: A Case Report

CD 30 ligand could be a new therapeutic target for central nervous system autoimmunity

Central nervous system-specific antinuclear antibodies in patients with multiple sclerosis

Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis

Long-term use of interferon-[beta] in multiple sclerosis increases V[delta]1-V[delta]2-V[gamma]9- [gamma][delta] T cells that are associated with a better outcome

Requirement of CD30 expression on CD4 T cells in the pathogenesis of experimental autoimmune encephalomyelitis

Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study

Re-emergence of a tumefactive demyelinating lesion after initiation of fingolimod therapy

A novel mutation in FGD4 causes Charcot–Marie–Tooth disease type 4H with cranial nerve involvement

Suchergebnisse filtern